Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Time Posted：2020-06-04 19:51
On June 1, the Shanghai Stock Exchange (SSE) announced that, according to index rules and after deliberation by the index expert committee, the SSE and the China Securities Index Co., Ltd. decided to adjust the constituent stocks of the SSE 50, SSE 180, and SSE 380 indices on June 15, 2020. The SSE 50 index will replace 5 stocks, the SSE 180 index will replace 18 stocks, and the SSE 380 index will replace 38 stocks. As a pharmaceutical listed company with strong profitability, growth potential, and industry representation, Health and Wellness (600380) has been added to the constituent stocks of the SSE 380 index in this adjustment.
Time Posted：2020-06-02 19:48
On June 1st, a donation signing ceremony for Joincare Pharmaceutical Group Industry Co., Ltd. & Lizhu Pharmaceutical's chronic disease poverty alleviation project in Pingwu County was held in Gaocun Township. Jing Xiangjun, Standing Committee Member of the County Committee and Secretary of the Political and Legal Committee; Zheng Maojun, Deputy County Magistrate; Wang Dezhi, Vice President of the Taohuayuan Ecological Protection Foundation; and Liu Jia, Director of Public Affairs at Joincare Pharmaceutical Group Industry Co., Ltd., attended the signing ceremony.
Time Posted：2020-05-28 20:26
Recently, RKS, a third-party rating agency, Runling Global Responsibility Rating, released its first ESG rating for the constituent stocks of the CSI 800 Index. The RKS rating results show that among the 800 A-share constituent companies, 30 companies, including Health-Yuan, GF Securities, Industrial Bank, and Ping An Insurance, have relatively good ESG performance and are rated BBB, while over 80% of the A-share constituent companies are rated B or below.
Jiaozuo Jiankangyuan: Technological Innovation Promotes High-Quality Development
Time Posted：2020-05-21 19:59
Only by firmly grasping the initiative in technological innovation can we establish ourselves in the industry, enter the market, and seek survival and development.
Time Posted：2020-04-27 20:02
Company 1Q20 achieved operating revenue of 3.187 billion yuan (-4.63% yoy), net profit attributable to shareholders of 280 million yuan (-8.39% yoy), and non-net profit of 281 million yuan (+1.66% yoy).
Time Posted：2020-04-27 17:54
Earnings forecast and valuation rating. Considering the impact of the epidemic on the price increase of raw materials and the launch of blockbuster inhaled products, we have raised the EPS for 20-22 to 0.55 yuan/0.64 yuan/0.76 yuan respectively, with a year-on-year growth of 20.0%/16.5%/18.6%. The company's inhaled product layout is comprehensive, and blockbuster products are expected to enter the harvest period. We maintain a "Buy" rating.
Time Posted：2020-04-18 18:01
Recently, the second-quarter drug distribution work of the "Chronic Disease Poverty Alleviation" project, jointly initiated by Health Spring, Lizhu Group, and the Taohuayuan Foundation in Xianghai National Nature Reserve, was successfully completed locally.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.